Works matching UCLA Jonsson Comprehensive Cancer Center

Results: 699
    1
    2
    3
    4
    5
    6
    7

    Dispatches.

    Published in:
    Frontiers in Ecology & the Environment, 2003, v. 1, n. 4, p. 172, doi. 10.1890/1540-9295(2003)001[0172:D]2.0.CO;2
    Publication type:
    Article
    8
    9
    10

    Somatic Tumor Next-Generation Sequencing in US Veterans With Metastatic Prostate Cancer.

    Published in:
    JAMA Network Open, 2025, v. 8, n. 5, p. e259119, doi. 10.1001/jamanetworkopen.2025.9119
    By:
    • Valle, Luca F.;
    • Li, Jiannong;
    • Desai, Heena;
    • Hausler, Ryan;
    • Haroldsen, Candace;
    • Chatwal, Monica;
    • Ojo, Matthias;
    • Kelley, Michael J.;
    • Rebbeck, Timothy R.;
    • Rose, Brent S.;
    • Rettig, Matthew B.;
    • Nickols, Nicholas G.;
    • Garraway, Isla P.;
    • Yamoah, Kosj;
    • Maxwell, Kara N.
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17

    Treatment utilization and overall survival in patients receiving radical nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma: evaluation of updated treatment guidelines.

    Published in:
    World Journal of Urology, 2019, v. 37, n. 6, p. 1157, doi. 10.1007/s00345-018-2506-1
    By:
    • Upfill-Brown, Alexander;
    • Lenis, Andrew T.;
    • Faiena, Izak;
    • Salmasi, Amirali H.;
    • Johnson, David C.;
    • Pooli, Aydin;
    • Drakaki, Alexandra;
    • Gollapudi, Kiran;
    • Blumberg, Jeremy;
    • Pantuck, Allan J.;
    • Chamie, Karim
    Publication type:
    Article
    18

    Prospective phase II trial of the dual mTORC1/2 inhibitor vistusertib for progressive or symptomatic meningiomas in persons with neurofibromatosis 2.

    Published in:
    Neuro-Oncology Advances, 2023, v. 5, n. 1, p. 1, doi. 10.1093/noajnl/vdad041
    By:
    • Jordan, Justin T;
    • Orr, Christina C;
    • Thalheimer, Raquel D;
    • Cambillo, Josephine V;
    • Beauchamp, Roberta L;
    • Shaikh, Ghalib;
    • Muzikansky, Alona;
    • Stemmer-Rachamimov, Anat;
    • Giovannini, Marco;
    • Kalamarides, Michel;
    • Barker, Fred G;
    • Ramesh, Vijaya;
    • Plotkin, Scott R
    Publication type:
    Article
    19
    20

    Prostate cancer polygenic risk score and prediction of lethal prostate cancer.

    Published in:
    NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00266-8
    By:
    • Klein, Robert J.;
    • Vertosick, Emily;
    • Sjoberg, Dan;
    • Ulmert, David;
    • Rönn, Ann-Charlotte;
    • Häggström, Christel;
    • Thysell, Elin;
    • Hallmans, Göran;
    • Dahlin, Anders;
    • Stattin, Pär;
    • Melander, Olle;
    • Vickers, Andrew;
    • Lilja, Hans
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33

    Nidogen‐1 Mitigates Ischemia and Promotes Tissue Survival and Regeneration.

    Published in:
    Advanced Science, 2021, v. 8, n. 4, p. 1, doi. 10.1002/advs.202002500
    By:
    • Zbinden, Aline;
    • Layland, Shannon L.;
    • Urbanczyk, Max;
    • Carvajal Berrio, Daniel A.;
    • Marzi, Julia;
    • Zauner, Monika;
    • Hammerschmidt, Anne;
    • Brauchle, Eva M.;
    • Sudrow, Katrin;
    • Fink, Simon;
    • Templin, Markus;
    • Liebscher, Simone;
    • Klein, Gerd;
    • Deb, Arjun;
    • Duffy, Garry P.;
    • Crooks, Gay M.;
    • Eble, Johannes A.;
    • Mikkola, Hanna K. A.;
    • Nsair, Ali;
    • Seifert, Martina
    Publication type:
    Article
    34
    35

    Is polycystic kidney disease associated with malignancy in children?

    Published in:
    Molecular Genetics & Genomic Medicine, 2019, v. 7, n. 7, p. N.PAG, doi. 10.1002/mgg3.725
    By:
    • Friend, Brian D.;
    • Wolfe Schneider, Kami;
    • Garrington, Timothy;
    • Truscott, Laurel;
    • Martinez‐Agosto, Julian A.;
    • Venick, Robert S.;
    • Tsai Chambers, Eileen;
    • Weng, Patricia;
    • Farmer, Douglas G.;
    • Chang, Vivian Y.;
    • Federman, Noah
    Publication type:
    Article
    36
    37
    38
    39
    40

    Elacestrant (ELA) vs Standard of Care (SOC) in ER+/HER2-- Advanced (adv) or Metastatic Breast Cancer (mBC) With ESR1 Mutation (ESR1-mut): Key Biomarkers and Clinical Subgroup Analyses From the Phase 3 EMERALD Trial.

    Published in:
    Journal of Oncology Navigation & Survivorship, 2024, v. 15, n. 10, p. 310
    By:
    • Bardia, Aditya;
    • O'Shaughnessy, Joyce;
    • Bidard, Francois-Clement;
    • Aftimos, Phillipe;
    • Cortes, Javier;
    • Lu, Janice;
    • Tonini, Giulia;
    • Thea, Kathy Puyana;
    • Paoli, Alessandro;
    • Kaklamani, Virginia
    Publication type:
    Article
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50